产品名称
D-半胱氨酸, ≥99% (RT)
Quality Level
assay
≥99% (RT)
form
powder or crystals
optical activity
[α]20/D −7.6±1.0°, c = 5% in 5 M HCl
reaction suitability
reaction type: solution phase peptide synthesis
mp
~230 °C (dec.)
application(s)
peptide synthesis
SMILES string
N[C@H](CS)C(O)=O
InChI
1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m1/s1
InChI key
XUJNEKJLAYXESH-UWTATZPHSA-N
Application
半胱氨酸已用于QD的功能化,可应用于光催化作用。
也可用于以下物质的合成:
也可用于以下物质的合成:
- 基于半胱氨酸的手性碳点(CD)
- D-荧光素和氨基荧光素类似物
Packaging
无底玻璃瓶。内含物在插入的融合锥体内。
Other Notes
半胱氨酸的非天然异构体。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Angéla Takács et al.
Scientific reports, 10(1), 14287-14287 (2020-09-02)
Bortezomib (BOZ) is a proteasome inhibitor chemotherapeutic agent utilized to treat multiple myeloma and recently offered to cure melanoma. Bortezomib-induced neuropathy is one of the dose-limiting side-effects, which can be treated with antioxidants (e.g. alpha-lipoic acid-ALA and Vitamin B1-vit B1).
Jing Wang et al.
Nanomaterials (Basel, Switzerland), 8(12) (2018-12-14)
Chiral recognition is of fundamental importance in chemistry and life sciences and the principle of chiral recognition is instructive in chiral separation and enantioselective catalysis. Non-chiral Ag nanoparticles (NPs) conjugated with chiral cysteine (Cys) molecules demonstrate strong circular dichroism (CD)
Yusuke Shibui et al.
Journal of toxicologic pathology, 30(3), 217-229 (2017-08-12)
Two 4-week repeated-dose toxicity studies were conducted to evaluate the potential toxicity of l-cysteine and d-cysteine. In one study, three groups of 6 male rats were each administered l-cysteine once daily by gavage at doses of 500, 1,000, or 2,000
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 30095-100MG | 04061826660713 |
| 30095-1G | 04061826662182 |
